Current Edition


Key Bristol Myers drug holds up in long-term psoriasis study

Dive Brief: An experimental psoriasis drug developed by Bristol Myers Squibb maintained its effectiveness over more than a year of treatment in a clinical trial …

Continue Reading →

Pressure rises as Gilead awaits important study results for top cancer drug

Gilead lost several billion dollars in market value Wednesday after unnerving investors with updates about a key clinical trial of its most closely watched breast …

Continue Reading →